US: +1 617 696-7335 | EU: +31 317 728 104|info@ionoptix.com

Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo (2025)

2026-05-15T18:00:08-05:00

Shuvaev VV, Tam YK, Lee BW, Myerson JW, Herbst A, Kiseleva RY, Glassman PM, Parhiz H, Alameh MG, Pardi N, Muramatsu H, Shuvaeva TI, Arguiri E, Marcos-Contreras OA, Hood ED, Brysgel TV, Nong J, Papp TE, Eaton DM, Riley R, Palanki R, Musunuru K, Brenner JS, Mitchell MJ, Ferrari VA, Mui BL, Semple SC, Weppler SA, Atluri P, Margulies KB, Weissman D, Muzykantov VR. Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo. Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2409266122. doi: 10.1073/pnas.2409266122.

Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo (2025)2026-05-15T18:00:08-05:00

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids (2024)

2026-05-15T18:57:47-05:00

Desai D, Song T, Singh RR, Baby A, McNamara J, Green LC, Nabavizadeh P, Ericksen M, Bazrafshan S, Natesan S, Sadayappan S. MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids. Cells. 2024 Nov 19;13(22):1913. doi: 10.3390/cells13221913.

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids (2024)2026-05-15T18:57:47-05:00

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (JOVE VIDEO)(2023)

2026-05-27T10:10:01-05:00

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Dinani R, Manders E, Helmes M, Wang L, Knollmann B, Kuster DWD, van der Velden J. J Vis Exp. 2023 May 26;(195). doi: 10.3791/65326.

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (JOVE VIDEO)(2023)2026-05-27T10:10:01-05:00
Go to Top